Literature DB >> 20149816

Medial forebrain stimulation enhances intracranial nociception and attenuates morphine analgesia suggesting the existence of an endogenous opioid antagonist.

Conan Kornetsky1, Clifford M Knapp, Lisa Tozier, Arlene Pak.   

Abstract

The purpose of this experiment was to test in the rat the hypotheses that activation of the brain reward system would attenuate the effects of intracranial nociceptive stimulation and would potentiate the antinociceptive effects of morphine. In this experiment pain (nociception) was generated by electrical stimulation of a brain pain pathway, the mesencephalic reticular formation (MRF) of the rat. Reward pathway stimulation was to the medial forebrain bundle at the level of the lateral hypothalamus (MFB-LH). Current thresholds for escape from MRF stimulation were determined using a modification of the psychophysical methods of limits. MRF stimulation was delivered concurrently with different intensities of non-contingent MFB-LH stimulation. The effects of morphine and saline were determined under all stimulation conditions. Contrary to expectation MFB-LH stimulation significantly lowered MRF stimulation escape thresholds. Morphine administration elevated MRF thresholds in the absence of MFB-LH stimulation. However, this effect was blocked by concurrent MFB-LH stimulation. These findings, which mimic the effects of the opiate antagonist naloxone, i.e., potentiating of pain and antagonism of morphine's analgesic effects, suggest the presence of an endogenous opiate receptor antagonist. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20149816      PMCID: PMC2859829          DOI: 10.1016/j.pbb.2010.01.015

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  37 in total

1.  Interactions between rewarding lateral hypothalamic and aversive nucleus reticularis gigantocellularis stimulation.

Authors:  M Diotte; M Miguelez; E Miliaressis; C Bielajew
Journal:  Behav Brain Res       Date:  2000-12-05       Impact factor: 3.332

2.  Analgesia for tonic pain by self-administered lateral hypothalamic stimulation.

Authors:  R Lopez; V C Cox
Journal:  Neuroreport       Date:  1992-04       Impact factor: 1.837

3.  Potentiation of morphine analgesia by d-amphetamine.

Authors:  S Sasson; E M Unterwald; C Kornetsky
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Morphine: ability to block neuronal activity evoked by a nociceptive stimulus.

Authors:  H J Haigler
Journal:  Life Sci       Date:  1976-09-15       Impact factor: 5.037

5.  Excitatory connection from lateral hypothalamic self-stimulation sites to escape sites in medullary reticular formation.

Authors:  J J Keene; K L Casey
Journal:  Exp Neurol       Date:  1970-07       Impact factor: 5.330

6.  Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; S J Watson
Journal:  J Comp Neurol       Date:  1999-04-19       Impact factor: 3.215

7.  Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.

Authors:  J L Wang; C B Zhu; X D Cao; G C Wu
Journal:  Regul Pept       Date:  1999-02-05

Review 8.  Modulatory role of neuropeptide FF system in nociception and opiate analgesia.

Authors:  Hsiu-Ying T Yang; Tao Tao; Michael J Iadarola
Journal:  Neuropeptides       Date:  2007-09-12       Impact factor: 3.286

9.  A differential modulation of allodynia, hyperalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic rats: interactions with morphine and naloxone.

Authors:  H Wei; P Panula; A Pertovaara
Journal:  Neuroscience       Date:  1998-09       Impact factor: 3.590

10.  Morphine and methionine-enkephalin: different effects on spontaneous and evoked neuronal firing in the mesencephalic reticular formation of the rat.

Authors:  D A Hosford; H J Haigler
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.